CRSP News
CRISPR Therapeutics AG
$45.75
+$0.60(+1.33%)
40
Overall
60
Value
10
Tech
50
Quality
Market Cap
$4.44B
Volume
2.67M
52W Range
$44.12 - $63.45
Target Price
$82.58
CRSP news: the latest CRISPR Therapeutics AG headlines, press releases and market updates, newest first.
Latest CRSP News
- Crispr Therapeutics AG (CRSP) Receives a Hold from RBC CapitalTipRanks Auto-Generated Intelligence Newsdesk · Nov 4, 2026
- Analysts’ Top Healthcare Picks: Crispr Therapeutics AG (CRSP), Faeth Therapeutics (FTH)TipRanks Newsroom · Nov 3, 2026
- Crispr Therapeutics AG (CRSP) Receives a Buy from Piper SandlerTipRanks Auto-Generated Intelligence Newsdesk · Nov 3, 2026
- Crispr Therapeutics Expands Into Autoimmune Neurology With New CTX112 TrialTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 22, 2026
- Crispr Therapeutics AG (CRSP) Receives a Rating Update from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Oct 21, 2026
- Amprius, Viking, Regeneron, Ionis, Crispr Trending With AnalystsTipRanks Weekend Auto-Generated Newsdesk · Oct 17, 2026
- Crispr Therapeutics AG (CRSP) Receives a New Rating from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
- Cathie Wood Just Sold $3.36M in META Stock. Here’s What She Bought InsteadKirti Tak · Oct 13, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRSP | $45.75 | +1.3% | 2.67M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |